SOURCE: Ingen Technologies, Inc.

Ingen Technologies, Inc.

August 08, 2012 08:30 ET

Ingen Technologies, Inc. Announces Future Acquisition Plans

Several Acquisition Planned Over the Next 12 Months; The First in Just Days

RIVERSIDE, CA--(Marketwire - Aug 8, 2012) - Ingen Technologies, Inc. (PINKSHEETS: IGNT), an emerging medical device manufacturer with proprietary medical products for the growing $4B respiratory markets announced today that the company Chairman, Gary B. Tilden, has made the following statements regarding an upcoming acquisition.

"I am very pleased to announce that Ingen will be making several acquisitions over the next 12 months as a part of its Plan of Reorganization. The first acquisition should be announced in the next few days regarding a company with a proprietary, patented line of products for the healthcare industry. This is a monumental step forward for Ingen in building a solid foundation in which to grow upon. We believe that we have a strong medical product base that will continue to create longevity for our overall increasing revenue base. In addition, the potential market for our respiratory product line is approximately $200 million annually; and the new addition of this upcoming acquisition will open up new markets for Ingen in the healthcare and health & fitness industry."


Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

Contact Information